Found: 9
Select item for more details and to access through your institution.
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 545, doi. 10.1159/000518104
- By:
- Publication type:
- Article
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 3, p. 721, doi. 10.3390/cells9030721
- By:
- Publication type:
- Article
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10718, doi. 10.3390/ijms241310718
- By:
- Publication type:
- Article
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 7791, doi. 10.3390/ijms24097791
- By:
- Publication type:
- Article
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6123, doi. 10.3390/ijms24076123
- By:
- Publication type:
- Article
miR‐21‐5p promotes NASH‐related hepatocarcinogenesis.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2256, doi. 10.1111/liv.15682
- By:
- Publication type:
- Article
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets.
- Published in:
- Liver International, 2020, v. 40, n. 7, p. 1670, doi. 10.1111/liv.14485
- By:
- Publication type:
- Article
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89236-x
- By:
- Publication type:
- Article
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets.
- Published in:
- Biomedicines, 2022, v. 10, n. 1, p. 46, doi. 10.3390/biomedicines10010046
- By:
- Publication type:
- Article